National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 568 cases where Vaccine is RV1 and Symptom is Intussusception and Appearance Date from '2008-02-01' to '2014-12-31'

Case Details

This is page 38 out of 57

Result pages: prev   29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47   next


VAERS ID: 407588 (history)  
Form: Version 1.0  
Age: 0.2  
Sex: Unknown  
Location: Foreign  
Vaccinated:2010-10-05
Onset:2010-10-12
   Days after vaccination:7
Submitted: 2010-10-28
   Days after onset:16
Entered: 2010-10-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Intestinal resection, Intussusception
SMQs:, Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0680141A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 3-month-old subject of unspecified gender who was was vaccinated with ROTARIX (GlaxoSmithKline). On 5 October 2010, the subject received 1st dose of ROTARIX (oral), lot number not provided. On 12 October 2010, 7 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised for surgical resection of bowels affected. At the time of reporting the outcome of the events was unspecified.


VAERS ID: 407921 (history)  
Form: Version 1.0  
Age: 0.32  
Sex: Male  
Location: Foreign  
Vaccinated:2010-10-09
Onset:2010-10-20
   Days after vaccination:11
Submitted: 2010-11-05
   Days after onset:16
Entered: 2010-11-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Abdominal distension, Abdominal mass, Haematochezia, Intestinal anastomosis, Intestinal gangrene, Intestinal resection, Intussusception, Surgery
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0682689A

Write-up: This case was reported by a physician and described the occurrence of ileocolic intussusception in a 4-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). No other contributory past or family history. Previous and/or concurrent vaccination included ROTARIX; GlaxoSmithKline; oral given on 15 September 2010. On 9 October 2010 the subject received 2nd dose of ROTARIX (oral), lot number not provided. On 20 October 2010, 11 days after vaccination with 2nd dose of ROTARIX, the subject experienced ileocolic intussusception. The same day the subject was brought to hospital due to currant jelly coloured stools. Antibiotics were prescribed but the subject returned back with abdominal distension and lump per abdomen. The subject was referred to paediatric surgeon who diagnosed the patient clinically as intussusception and the subject was operated immediately within 2-3 hours of diagnosis. The diagnostic was ileocaecal-colic intussusception and required resection anastomosis as the segment was gangrenous. The subject was kept in hospital for 5-6 days and then discharged. The physician considered the events were life threatening. The subject was followed up and at the time of reporting was normal. The physician considered the events were possibly related to vaccination with ROTARIX.


VAERS ID: 410701 (history)  
Form: Version 1.0  
Age: 0.3  
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2010-11-30
Entered: 2010-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Adenovirus test, Bronchiolitis, Intussusception, Rotavirus test negative
SMQs:, Interstitial lung disease (narrow), Gastrointestinal obstruction (narrow), Eosinophilic pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Adenovirus test, Negative; Rotavirus test, Negative
CDC Split Type: B0686483A

Write-up: This case was reported by a healthcare professional and described the occurrence of invagination of intestine in a 3-month-old male subject who was vaccinated with ROTARIX, (GlaxoSmithKline). On an unspecified date, the subject received 1st dose of ROTARIX (oral, batch number not provided). At an unspecified time after vaccination with ROTARIX, the subject experienced invagination of intestine. The subject was hospitalised 6 days after vaccination with ROTARIX due to acute bronchiolitis. Relevant tests were performed and showed excreta negative for rotavirus and adenovirus. At the time of reporting, the outcome of the events was unspecified.


VAERS ID: 411298 (history)  
Form: Version 1.0  
Age: 0.3  
Sex: Male  
Location: Foreign  
Vaccinated:2010-11-15
Onset:2010-11-20
   Days after vaccination:5
Submitted: 2010-12-02
   Days after onset:12
Entered: 2010-12-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (NO BRAND NAME) / SANOFI PASTEUR - / UNK UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AROLA118BB / 1 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Haematochezia, Intussusception, Mucous stools, Saline infusion sonogram, Ultrasound abdomen abnormal, Vomiting
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Diagnostic ultrasound, Nov2010, see text
CDC Split Type: B0686203A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 3-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject''s brother (twin) was also vaccinated with both vaccines on the same day. No adverse event occurred. Concurrent vaccination included PENTAXIM (no GSK) given on 15 November 2010. On 15 November 2010 the subject received 1st dose of ROTARIX (oral). On 20 November 2010, 5 days after vaccination with ROTARIX, the subject was directed to hospital due to the suspicion of intussusception. The subject experienced the following symptoms vomiting, bloody stools (a lot of fresh blood) and mucus (nos). The physician considered the events were clinically significant (or requiring intervention). No surgery was performed. Intussusception was resolved with a conservative procedure (with saline solution and they observed the procedure with ultrasound. At the time of reporting the events were resolved. The physician did not receive yet the hospital summary report.


VAERS ID: 412834 (history)  
Form: Version 1.0  
Age: 0.38  
Sex: Male  
Location: Foreign  
Vaccinated:2010-10-13
Onset:2010-10-24
   Days after vaccination:11
Submitted: 2010-12-15
   Days after onset:52
Entered: 2010-12-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AROLA118BB / 1 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Crying, Fatigue, Haematochezia, Intussusception, Mucous stools, Saline infusion sonogram
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Depression (excl suicide and self injury) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: HEALTHY BABY
Allergies:
Diagnostic Lab Data: Ultrasound examination, see text
CDC Split Type: B0688103A

Write-up: This case was reported by a regulatory authority (# SI-JAZMP-NCPHV-2010SI0120_574) and described the occurrence of invagination of colon in a 4 and a half month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject''s medical history included healthy baby. No medication was used. On 13 October 2010 the subject received 1st dose of ROTARIX (oral). On 24 October 2010, 11 days after vaccination with ROTARIX, the subject experienced abdominal pain, bloody mucous stool, tiredness, persisting crying. The subject was hospitalised and invagination was diagnosed. The subject was treated conservatively with saline solution under ultrasound supervision. The reaction was resolved and the subject was discharged on 26 October 2010. On 29 October 2010, 3 days after the subject was again brought to hospital where again invagination of colon was diagnosed and treated in the same manner as it was for the 1st time. On 31 October 2010 the subject was discharged. Afterwards he was completed recovered. The regulatory authority reported that the events were possibly related to vaccination with ROTARIX. No further information was expected.


VAERS ID: 416993 (history)  
Form: Version 1.0  
Age: 0.33  
Sex: Male  
Location: Foreign  
Vaccinated:2010-12-29
Onset:2011-01-23
   Days after vaccination:25
Submitted: 2011-02-16
   Days after onset:24
Entered: 2011-02-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CB068A / 2 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Intestinal resection, Intussusception, Laparotomy
SMQs:, Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0698840A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 5-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included ROTARIX; GlaxoSmithKline; oral given on 31 October 2010. On 29 December 2010, the subject received 2nd dose of ROTARIX (oral). On 23 January 2011, 25 days after vaccination with ROTARIX, the subject experienced intussusception. A laparotomy resection was performed as treatment. The subject was hospitalised. On 24 January 2011, the events were resolved. The physician considered the intussusception was almost certainly related to vaccination with ROTARIX.


VAERS ID: 418075 (history)  
Form: Version 1.0  
Age: 0.21  
Sex: Female  
Location: Foreign  
Vaccinated:2011-01-14
Onset:2011-01-19
   Days after vaccination:5
Submitted: 2011-03-04
   Days after onset:44
Entered: 2011-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AROLA251AC / 1 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Haematochezia, Intussusception, Surgery, Vomiting
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0702794A

Write-up: This case was reported by a physician via regulatory authority (# PT-INFARMED-L201102-353) and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). No relevant medical history was provided. No previous reaction to any drug. On 14 January 2011, the subject received 1st dose of ROTARIX (oral). On 19 January 2011, 5 days after vaccination with ROTARIX, the subject experienced invagination of intestine, blood in stools, colic and vomiting. The subject was hospitalised for 6 days (from 19 to 24 January 2011) and the regulatory authority reported that the events were life threatening. The subject was treated with surgery to reduce intussusception. On 24 January 2011, the events were resolved. The regulatory authority reported that the events were possibly related to vaccination with ROTARIX. There is no suspicion of drug interaction. No further information is expected, the regulatory Authority has provided GSK with all the available information for the time being, if they ever get any further information they will send it to GSK. The case has been closed. Until now, the 2nd dose was not reintroduce and it was unknown if it would be given later.


VAERS ID: 418470 (history)  
Form: Version 1.0  
Age: 0.4  
Sex: Male  
Location: Foreign  
Vaccinated:2011-02-13
Onset:2011-02-21
   Days after vaccination:8
Submitted: 2011-03-11
   Days after onset:18
Entered: 2011-03-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HIBV: HIB (HIBERIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH - / UNK UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Abdominal X-ray, Abdominal mass, Barium double contrast, Diarrhoea haemorrhagic, Enema administration, Intussusception, Surgery, Vomiting, X-ray abnormal
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Pseudomembranous colitis (broad), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Noninfectious diarrhoea (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray, Feb2011, See text units
CDC Split Type: B0704423A

Write-up: This case was reported by a physician via a representative and described the occurrence of intussusception in a 5-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). There was no family history of intussusception or bowel abnormalities. The subject''s medical history did not include intra-abdominal surgery, no intestinal or gastrointestinal malformation or dysfunction. Concurrent vaccination included HIBERIX (GlaxoSmithKline; route and injection site unknown) and PREVNAR (non-gsk) (Wyeth Labs; route and injection site unknown) given on 13 February 2011. On 13 February 2011, the subject received unspecified dose of ROTARIX (oral, batch number not provided). On 21 February 2011, 8 days after vaccination with ROTARIX, the subject experienced vomiting. On 23 February 2011, 10 days after vaccination with ROTARIX, the subject suffered from bloody diarrhea. The subject was hospitalised. The physician examined the subject and diagnosed as intussusceptions because he felt a mass in hypochondria and left ilica fossa. Plain abdominal radiograph showed a visible intussusceptum or soft tissue mass and did not show non-specific abnormalities, any fluid levels or dilated bowel loops. Air or liquid contrast enema did not demonstrate invagination of the intestine. No abdominal ultrasound was performed and no computerized tomogram. The subject was made with surgerical operation for correction of intussusception (reduction without resection). On 26 February 2011, the events were resolved. There were no complications of radiological procedure or of surgery. The physician considered the events were probably related to vaccination with ROTARIX.


VAERS ID: 419017 (history)  
Form: Version 1.0  
Age: 0.32  
Sex: Male  
Location: Foreign  
Vaccinated:2010-09-14
Onset:2010-09-19
   Days after vaccination:5
Submitted: 2011-03-17
   Days after onset:179
Entered: 2011-03-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (NO BRAND NAME) / SANOFI PASTEUR - / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41FB067A / 1 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound scan
SMQs:, Gastrointestinal obstruction (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0701395A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent vaccination included DTPA-POLIO-HIB (non-gsk) (manufacturer unspecified; intramuscular; injection site unknown) given on 14 September 2010. On 14 September 2010, the subject received 1st dose of ROTARIX (oral). On 19 September 2010, 5 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was clinically significant (or requiring intervention). After diagnostic imaging, the subject was treated with surgery on 29 September 2010. At the time of reporting, the event was resolved. The physician considered the event was possibly related to vaccination with ROTARIX. Follow-up information received on 8 March 2011: The date of surgery was corrected: the surgery was performed on 23 September 2010 and on 23 September 2010, the event was resolved.


VAERS ID: 419514 (history)  
Form: Version 1.0  
Age: 0.29  
Sex: Male  
Location: Foreign  
Vaccinated:2011-02-05
Onset:2011-02-10
   Days after vaccination:5
Submitted: 2011-03-25
   Days after onset:42
Entered: 2011-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal
SMQs:, Retroperitoneal fibrosis (broad), Gastrointestinal obstruction (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Ultrasound abdomen, 11Feb2011, suggestive of in
CDC Split Type: B0707294A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 3-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). No contributing history. On 5 February 2011, the subject received 1st dose of ROTARIX (oral, batch number not provided). On 10 February 2011, 5 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). On 11 February 2011, the ultrasonography of abdomen was suggestive of intussusception. No necrosis of bowel was observed, no bowel resection done. The subject was treated with surgery for reduction of intussusception. On 11 February 2011, the event was resolved. The physician considered the event was almost certainly related to vaccination with ROTARIX. The physician considered that there was a temporal association with the administration of ROTARIX.


Result pages: prev   29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=38&SYMPTOMS[]=Intussusception_%2810022863%29&VAX[]=RV1&REPORT_YEAR_LOW=2008&REPORT_MONTH_LOW=02&REPORT_YEAR_HIGH=2014&REPORT_MONTH_HIGH=12


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166